Skip to main content

Table 4 Associations of MAPT haplotypes with age of CBD onset and disease duration

From: MAPT subhaplotypes in corticobasal degeneration: assessing associations with disease risk, severity of tau pathology, and clinical features

Haplotype

Haplotype frequency (%) (N = 188)

Association with age of CBD onset

Association with disease duration

β (95% CI)

P value

β (95% CI)

P value

H1b

21.6

− 0.48 (− 2.53, 1.56)

0.64

0.10 (− 0.52, 0.72)

0.76

H1c

15.1

− 1.10 (− 3.42, 1.22)

0.36

0.00 (− 0.71, 0.71)

0.99

H1d

10.8

1.18 (− 1.51, 3.88)

0.39

0.12 (− 0.70, 0.94)

0.78

H1e

6.7

0.05 (− 3.27, 3.37)

0.98

0.38 (− 0.63, 1.38)

0.46

H1h

4.9

− 1.00 (− 4.76, 2.76)

0.60

0.08 (− 1.06, 1.23)

0.89

H1i

6.3

− 1.62 (− 5.20, 1.96)

0.38

− 1.04 (− 2.12, 0.04)

0.061

H1k1

1.0

2.49 (− 7.51, 12.49)

0.63

− 2.60 (− 5.61, 0.41)

0.093

H1l

3.8

1.80 (− 2.49, 6.09)

0.41

0.31 (− 1.00, 1.62)

0.64

H1m

1.7

− 4.68 (− 12.23, 2.87)

0.23

− 2.01 (− 4.30, 0.28)

0.087

H1o

4.3

− 2.72 (− 7.19, 1.75)

0.24

− 0.48 (− 1.85, 0.88)

0.49

H1p

1.1

0.94 (− 7.98, 9.85)

0.84

3.42 (0.76, 6.08)

0.013

H1q

1.2

0.08 (− 7.97, 8.12)

0.99

− 0.06 (− 2.50, 2.38)

0.96

H1r

2.1

− 0.27 (− 6.67, 6.13)

0.93

0.87 (− 1.06, 2.81)

0.38

H1s2

1.3

1.11 (− 6.92, 9.13)

0.79

0.29 (− 2.15, 2.73)

0.82

H1u

4.4

2.56 (− 1.28, 6.41)

0.19

0.01 (− 1.17, 1.19)

0.98

H1v

1.3

0.42 (− 7.03, 7.87)

0.91

1.79 (− 0.46, 4.03)

0.12

H1x

1.9

0.66 (− 5.57, 6.90)

0.84

− 0.20 (− 2.09, 1.69)

0.84

H2

7.7

1.23 (− 1.58, 4.04)

0.39

− 0.02 (− 0.87, 0.84)

0.97

  1. β values, 95% CIs, and P values result from score tests of association that were adjusted for sex (age of CBD onset analysis) or sex and age of CBD onset (disease duration analysis). β values correspond to each additional copy of the given haplotype. P values < 0.0028 are considered as statistically significant after applying a Bonferroni correction for multiple testing
  2. CBD corticobasal degeneration, β regression coefficient, CI confidence interval
  3. 1The specific haplotype for H1k was not previously shown in Table 2 as this haplotype occurred at a frequency < 1% in the overall case–control series; this haplotype is A-A-A-C-A-G for the rs1467967-rs242557-rs3785883-rs2471738-rs8070723-rs7521 haplotype
  4. 2The specific haplotype for H1s was not previously shown in Table 2 as this haplotype occurred at a frequency < 1% in the overall case–control series; this haplotype is G-G-G-C-A-G for the rs1467967-rs242557-rs3785883-rs2471738-rs8070723-rs7521 haplotype